Flow cytometric DNA analysis on fine needle aspiration biopsies of liver lesions

Cytopathology

Volumn 13, Issue 5, 2002, Pages 273-283

  Granados, Rosario ^a   García vela, Jose Antonio ^a   Fenández Segoviano, Pilar ^a   Aramburu, José Antonio ^a   Martín, Isaac ^a   Murillo, Nieves ^a   Camarmo, Encarnación ^a   De La Cal, Miguel Angel ^a  

^a HOSPITAL UNIVERSITARIO DE GETAFE   (Spain)

Author keywords

DNA; Flow cytometry; FNA; Liver

Indexed keywords

ALPHA FETOPROTEIN; DNA;

ANEUPLOIDY; ARTICLE; ASPIRATION BIOPSY; CELL COUNT; CELL CYCLE S PHASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIPLOIDY; DNA DETERMINATION; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; LIVER CELL; LIVER CELL CARCINOMA; LIVER INJURY; METASTASIS; PRIORITY JOURNAL; BLOOD; GENETICS; LIVER TUMOR; METHODOLOGY; NEEDLE BIOPSY; PATHOLOGY; PROSPECTIVE STUDY;

ALPHA-FETOPROTEINS; ANEUPLOIDY; BIOPSY, NEEDLE; CARCINOMA, HEPATOCELLULAR; DNA, NEOPLASM; FLOW CYTOMETRY; HUMANS; LIVER NEOPLASMS; PROSPECTIVE STUDIES; S PHASE;

EID: 0036434421     PISSN: 09565507     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2303.2002.00413.x     Document Type: Article

References (29)

1. Cohen MB, Haber MM, Holly EA et al. Cytologic criteria to distinguish hepatocellular carcinoma from nonneoplastic liver. Am J Clin Pathol 1991; 95: 125-30.
2. Bottles K, Cohen MB, Holly EA et al. A step-wise logistic regression analysis of hepatocellular carcinoma. Cancer 1988; 62: 558-63.
3. Solé M, Calvet X, Cuberes T et al. Value and limitations of cytologic criteria for the diagnosis of hepatocellular carcinoma by fine needle aspiration biopsy. Acta Cytol 1993; 37: 309-16.
4. Koss LG, Czerniak B, Herz F, Wersto RP. Flow cytometric measurements of DNA and other cell components in human tumors: A critical appraisal. Hum Pathol 1989; 20: 528-48.
5. Mellin W, Grundmann E. Flow cytometric analysis of stemline heterogeneity. Pathol Res Pract 1989; 184: 6-10.
6. Fujimoto J, Okamoto E, Yamanaka N, Toyosaka A, Mitsonobu M. Flow cytometric DNA analysis of hepatocellular carcinoma. Cancer 1991; 67: 939-44.
7. Ezaki T, Kanematsu T, Okamura T, Sonoda T, Sugimachi K. DNA analysis of hepatocellular carcinoma and clinicopathologic implications. Cancer 1988; 61: 106-9.
8. Nagasue N, Yamanoi A, Takemoto Y et al. Comparison between diploid and aneuploid hepatocellular carcinomas. A flow cytometric study. Br J Surg 1992; 79: 667-70.
9. Chen MF, Hwang TL, Tsao KC, Sun CF, Chen TJ. Flow cytometric DNA analysis of hepatocellular carcinoma: Preliminary report. Surg 1991; 109: 455-8.
10. Zeppa P, Benincasa G, Troncone G et al. Retrospective evaluation of DNA ploidy of hepatocarcinoma on cytologic samples. Diagn Cytopathol 1998; 19: 323-9.
11. Deprez C, Vangansbeke D, Fastrez R et al. Nuclear DNA content, proliferation index, and nuclear size determination in normal and cirrrhotic liver, and in benign and malignant primary and metastatic hepatic tumors. Am J Clin Pathol 1993; 99: 558-65.
12. Sampatanukul P, Mikuz G, Israsena S, Vajarapongse K, Feichtinger H. Cytomorphologic and DNA cytometric features of hepatocellular carcinoma in fine needle aspirates. Acta Cytol 1997; 41: 435-42.
13. Melchiorri C, Bolondi L, Chieco P, Pagnoni M, Gramantieri L, Barbara L. Diagnostic and prognostic value of DNA ploidy and cell nuclearity in ultrasound-guided liver biopsies. Cancer 1994; 74: 1713-9.
14. Kuo SH, Sheu JC, Chen DS, Sun JL, Lin CC, Hsu HC. Cytophotometric measurements of nuclear DNA content in hepatocellular carcinomas. Hepatology 1987; 7: 330-2.
15. Cottier M, Jouffre C, Maubon I et al. Prospective flow cytometric DNA analysis of hepatocellular carcinoma specimens collected by ultrasound-guided fine needle aspiration. Cancer 1994; 74: 599-605.
16. Russo A, Bazan V, Plaja S, Cajozzo M, Bazan P. Flow cytometric DNA analysis of hepatic tumours on ultrasound-guided fine-needle aspirates. J Surg Oncol 1992; 51: 26-32.
17. Kuo SH, Lai MY, Liu YR et al. Nuclear area and DNA content in tumor and nontumor portions of hepatocellular carcinoma. Anal Quant Cytol Histol 1994; 16: 153-8.
18. McEntee GP, Batts A, Katzmann JA, Ilstrup DM, Nagorney DM. Relationship of nuclear DNA content to clinical and pathologic findings in patients with primary hepatic malignancy. Surgery 1992; 111: 376-9.
19. Kuo SH, Sheu JC, Chen DS et al. DNA clonal heterogeneity of hepatocellular carcinoma demonstrated by feulgen-DNA analysis. Liver 1987; 7: 359-63.
20. Wenming C, Mengchao W. The biopathologic characteristics of DNA content of hepatocellular carcinomas. Cancer 1990; 66: 498-501.
21. Vindelov LL, Christensen IJ, Nissen NI. A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 1983; 3: 323-7.
22. Shankey TV, Rabinovitch PS, Bagwell B et al. Guidelines for implementation of clinical DNA cytometry. Cytometry 1993; 14: 472-7.
23. Koike Y, Kamijyo K, Suzuki Y et al. DNA content of hepatocytes in various stages of liver cirrhosis. Liver 1985; 5: 156-61.
24. Williams RA, Baak JPA, Meijer GA, Charlton IG. Exploring the possibility of DNA ploidy measurements in tissue sections using liver as a model. Anal Quant Cytol Histol 1997; 19: 19-29.
25. Duque RE, Andreff M, Braylan RC, Diamond LW, Peiper SC. Consensus review of the clinical utility of DNA flow cytometry in neoplastic hematopathology. Cytometry 1993; 14: 492-6.
26. Hedley DW, Clark GM, Cornelisse CJ et al. Consensus review of the clinical utility of DNA cytometry in carcinoma of the breast. Cytometry 1993; 14: 482-5.
27. Shankey TV, Kallioniemi OP, Koslowski JM et al. Consensus review of the clinical utility of DNA content cytometry in prostate cancer. Cytometry 1993; 14: 497-500.
28. Bauer KD, Bagwell CB, Giaretti W et al. Consensus review of the clinical utility of DNA flow cytometry in colorectal cancer. Cytometry 1993; 14: 486-91.
29. Granados R, Fernández-Segoviano P, Aramburu JA, Murillo N, Camarmo E. Fine needle aspiration biopsy of liver masses: Diagnostic value and reproducibility of cytological criteria. Diagn Cytopathol 2001; 25: 365-375.